Treating insomnia in Swiss primary care practices: A survey study based on case vignettes.

Linder, Stefanie; Duss, Simone B.; Dvořák, Charles; Merlo, Christoph; Essig, Stefan; Tal, Kali; Del Giovane, Cinzia; Syrogiannouli, Lamprini; Heinzer, Raphael; Nissen, Christoph; Bassetti, Claudio L.A.; Auer, Reto; Maire, Micheline (2021). Treating insomnia in Swiss primary care practices: A survey study based on case vignettes. Journal of sleep research, 30(1), e13169. Wiley-Blackwell 10.1111/jsr.13169

Preview	Text Linder JSleepRes 2020_AAM.pdf - Accepted Version Available under License Publisher holds Copyright. Download (475kB) | Preview
	Text Linder_JSleepRes_2021.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (672kB)

Guidelines recommend cognitive behavioural therapy for insomnia (CBT-I) as first-line treatment for chronic insomnia, but it is not clear how many primary care physicians (PCPs) in Switzerland prescribe this treatment. We created a survey that asked PCPs how they would treat chronic insomnia and how much they knew about CBT-I. The survey included two case vignettes that described patients with chronic insomnia, one with and one without comorbid depression. PCPs also answered general questions about treating chronic insomnia and about CBT-I and CBT-I providers. Of the 820 Swiss PCPs we invited, 395 (48%) completed the survey (mean age 54 years; 70% male); 87% of PCPs prescribed sleep hygiene and 65% phytopharmaceuticals for the patient who had only chronic insomnia; 95% prescribed antidepressants for the patient who had comorbid depression. In each case, 20% of PCPs prescribed benzodiazepines or benzodiazepine receptor agonists, 8% prescribed CBT-I, 68% said they knew little about CBT-I, and 78% did not know a CBT-I provider. In the clinical case vignettes, most PCPs treated chronic insomnia with phytopharmaceuticals and sleep hygiene despite their lack of efficacy, but PCPs rarely prescribed CBT-I, felt they knew little about it, and usually knew no CBT-I providers. PCPs need more information about the benefits of CBT-I and local CBT-I providers and dedicated initiatives to implement CBT-I in order to reduce the number of patients who are prescribed ineffective or potentially harmful medications.

Interest & Impact

Downloads

318 since deposited on 15 Oct 2020
87 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item